Format

Send to

Choose Destination
Clin Sci (Lond). 2011 Apr;120(7):285-6. doi: 10.1042/CS20100553.

Hunting for fibrosis progression genes in hepatitis C patients.

Author information

1
Center for Autoimmune Liver Diseases, Division of Internal Medicine, IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Clinico Humanitas, 20089 Rozzano, Italy. pietro.invernizzi@humanitas.it

Abstract

HCV (hepatitis C virus) represents one of the major health problems worldwide, as almost 170 million people are infected and most of these develop a chronic disease, often with the progression to cirrhosis and its complications. In the present issue of Clinical Science, Iwata and co-workers report an association between a variant of a gene regulating bile acid levels, ABCB11 1331T>C (where ABCB11 encodes ATP-binding cassette, subfamily B, member 11), and the progression to cirrhosis in patients with HCV, but not in fatty liver patients. They correlate this genetic variant with increased serum bile acid levels as a marker of cholestasis. These findings have important implications for researchers working to dissect the molecular mechanisms underlying liver fibrogenesis and disease progression; however, the implications for clinical hepatologists are less immediate.

PMID:
21087209
DOI:
10.1042/CS20100553
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center